Self-assembly of Kaposi's sarcoma-associated herpesvirus capsids occurs when six proteins are coexpressed in insect cells using recombinant baculoviruses; however, if the small capsid protein (SCP) is omitted from the coinfection, assembly does not occur. Herein we delineate and identify precisely the assembly domain and the residues of SCP required for assembly. Hence, six residues, R14, D18, V25, R46, G66, and R70 in the assembly domain, when changed to alanine, completely abolish or reduce capsid assembly.
T
he Kaposi's sarcoma-associated herpesvirus (KSHV) capsid shell is made up of four proteins: the major capsid protein (MCP) encoded by open reading frame 25 (ORF25), triplex proteins 1 and 2 encoded by ORF62 and -26, respectively, and the small capsid protein (SCP) encoded by ORF65. The internal scaffold proteins (ORF17.5) are important for icosahedral capsid assembly and the serine protease (ORF17) for maturation of the capsid during genome packaging (1, 2, 6, 15, 17) . Self-assembly of capsids using recombinant baculoviruses for protein expression has been demonstrated for herpes simplex virus type 1 (HSV-1) (10, 11, 18, 19) and subsequently for KSHV and Epstein-Barr virus (EBV) (5, 13) . The assembly pathway of gammaherpesviruses (4, 9, 20, 21) was similar to that of HSV-1 with one exception: the SCP was essential for self-assembly (5, 13) . This was confirmed by mutation of ORF65 in a KSHV bacterial artificial chromosome (BAC) clone in infected cells (16) . The goal of this study was to use selfassembly of KSHV capsids in insect cells in conjunction with baculovirus expression systems to discover the assembly domain of the SCP and the important amino acids within this domain.
To do this, we used PCR methods to make N-terminal and C-terminal truncations of ORF65 using pFastBac1-ORF65 as a template (13) , and we transferred these into the baculovirus ex-pression vector pFastBac1 (Invitrogen) in order to test them for assembly. The forward primer specified a SpeI site and an inframe N-terminal influenza hemagglutinin (HA) epitope, and the reverse primer specified a HindIII site with the corresponding truncation (Fig. 1A) . Spodoptera frugiperda (Sf9 and Sf21) cells were used for these experiments and propagated as described by Okoye et al. (12) . Recombinant baculovirus generation methods are described by Okoye et al. (12) and Perkins et al. (13) . Expression of the truncated polypeptides was confirmed by Western blots using anti-HA antibody (Fig. 1B) . To facilitate our self-assembly experiments we also made dual-expression baculovirus recombinants. Thus, we cloned ORF25 and ORF17.5 into pFastBac Dual (Invitrogen) and we did the same for ORF62 and ORF26 (C. M. Capuano, D. Kreitler, B. H. Henson, E. N. Pryce, J. M. McCaffery, and P.J. Desai, unpublished data). We then coinfected Sf21 cells with FBD-ORF17.5/25, FBD-ORF26/62, FB-ORF17 (13) , and the baculovirus expressing wild-type or mutant ORF65 polypeptides. The coinfected cells were harvested and the lysates examined for capsids by sucrose gradient sedimentation and electron microscopy (EM) of negative-stained material from the gradients (Fig. 1C) . Visually, mutants expressing truncations at amino acids 86 and 125 gave strong light-scattering bands in sucrose gradients and closed icosahedral capsids when examined by EM. Mutants expressing truncations at amino acids 65 and 75 and the N-terminal truncation 87 did not yield capsids as judged by either method (data not shown). The 100-amino-acid mutant did not yield any capsids in several experiments. Because truncation at amino acid 86 supports assembly, we concluded that truncation at 100 amino acids, although stably expressed, may be misfolded. Thus, the assembly domain as shown for EBV SCP (5) resides in the N-terminal half of ORF65 polypeptide.
We next aligned the amino acid sequences of the gammaherpesvirus SCP, specifically focusing on the N-terminal 86 amino acids, to discover conserved residues within the assembly domain that could be targeted for mutagenesis. A major mutagenesis effort was made on several residues that were changed to alanine ( Fig. 2A and B) . The mutants were made in pFastBac1 containing the ORF65 gene and an HA epitope at the C terminus. To make this plasmid, ORF65 was amplified and cloned as a SpeI-HindIII fragment; the reverse primer specified the HindIII site and the HA epitope sequence (pFB1-ORF65CHA). An internal EcoRI recognition site in ORF65 was inactivated by silent site mutagenesis using QuikChange (Stratagene), and this plasmid served as the template for mutagenesis (pFB1-ORF65CHA-⌬EcoRI). ORF65 was also cloned into pFB1-CHA (5) as a BamHI-SpeI fragment (pFB1-ORF65CHA BS ). Mutants were made by QuikChange (7) or cassette PCR methods using Pfu Ultra (Stratagene) or Phusion polymerase (Finnzyme-NEB). The cloned wild-type and mutant genes were sequenced to check for authentic amplification. Mutants K5A and D8A were cloned as EcoRI-SpeI fragments into pFB1-CHA. The forward EcoRI primer contained the mutation. Mutants Y57A, Y58A, E59A, and Y61A were PCR amplified as BamHI-EcoRI fragments. The reverse primer contained the mutation and an EcoRI site. The resulting DNA fragment was cloned into a pFB1-ORF65CHA BS vector. All the mutants were tested for self-assembly using coinfections of Sf21 cells (Table 1) . Visually, many mutants gave strong light-scattering bands in sucrose gradients; this was confirmed by EM of material from the gradients (data not shown). For mutants R14A, D18A, V25A, R46A, Y58A, G66A, and R70A we did not detect a light-scattering band in the sucrose gradients and when material at the position where KSHV B capsid sediment was examined by EM, assembled capsids were not evident, indicating the loss of ORF65 assembly function. The stable accumulation of ORF65 expressed by these mutants was examined in insect cells using Western blots (Fig. 2C) . All mutants except Y58A expressed the ORF65 polypeptide. To demonstrate the assembly defect quantitatively, infected Sf21 cells (1 ϫ 10 7 ) were labeled with 250 Ci of 35 S-Express (Perkin Elmer) in unsupplemented Grace's insect cell medium from 42 to 72 h postinfection and then processed for sedimentation. Radioactivity in the peak fraction containing capsids was determined (Fig. 2D) , and the data show that radioactivity in this fraction for all mutant ORF65 gradients was 10-fold lower than in wild-type ORF65. The peak fractions were also examined for the presence of cosedimenting capsid proteins by SDS-PAGE (Fig. 2E) . In the presence of wild-type ORF65, radioactivity corresponding to the MCP, scaffold, and triplex proteins was evident in fraction 8. When mutant V25A polypeptide was present, radioactivity corresponding to the shell and scaffold proteins was detected but the signal was decreased and the same in all fractions. Furthermore, radioactivity corresponding to ORF65 was not evident.
Because R14A, D18A, and G66A mutants gave weak bands in sucrose gradients when the number of cells analyzed was increased, we examined all mutant infected cells by transmission EM methods (Fig. 3) . In the nuclei of infected cells, numerous cylindrical structures/tubules of varied lengths were observed (white arrow). Open capsid shells were also evident but, on close examination, are different from these shells and have the same repetitive indentation present in the long cylinders (black arrowheads, R46A right panel and V25A upper panel). Small circular structures of uniform size and a central core were also observed (white arrowheads, R70A panel and V25A lower panel), these could also be cross sections of the tubular structures. It is likely that all these structures are composed of the scaffold protein, based on data that show similar structures for the VZV scaffold protein (14) and for a mutant HCMV scaffold protein that has a weakened interaction with MCP (8). We did not see these structures when KSHV capsid assembly did not occur, but ORF17.5 was present (13) . None of these structures were evident in the sucrose gradient fractions examined for the mutants. This could be because they sediment to the bottom in the rate velocity sedimentation experiments or they are not stable in sucrose gradients. In cells infected with the G66A and D18A mutants we also observed regular icosahedral capsid structures (black arrows). How does ORF65 fit into this phenotype? Our hypothesis is that the mutant ORF65 polypeptides can still interact with MCP and they interfere with the MCP-scaffold protein interaction during shell accretion that causes the scaffold protein to disengage from the interaction with the outer shell and begin or continue an irreversible reaction that leads to the accumulation of elaborate scaffold structures.
In summary, the gammaherpesvirus SCP is an important mediator of stable capsid shell assembly and thus a new antiviral target. In this study, we show that the assembly domain of ORF65 resides in the N-terminal 86 residues. We made 35 alanine substitution mutations in the assembly domainof ORF65, and 6 abolish assembly. Mutants V25A, R46A, and R70A completely abrogate assembly, whereas mutants R14A, D18A, and G66A could support limited icosahedral capsid assembly. Thus, new sites of this pro- 
tein have been discovered that could form the basis for discovery of a small-molecule inhibitor.
